Metformin and breast and gynecological cancer risk among women with diabetes

OBJECTIVE: We investigated if metformin lowers breast, endometrial, and ovarian cancer risk in women with type 2 diabetes mellitus compared with women who used other antidiabetic medications. RESEARCH DESIGN AND METHODS: We followed a cohort of 66 778 female patients with diabetes for a maximum of 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Soffer, Diana, Shi, Jiaxiao, Chung, Joanie, Schottinger, Joanne E, Wallner, Lauren P, Chlebowski, Rowan T, Lentz, Scott E, Haque, Reina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316195/
https://www.ncbi.nlm.nih.gov/pubmed/25664181
http://dx.doi.org/10.1136/bmjdrc-2014-000049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316195/
https://www.ncbi.nlm.nih.gov/pubmed/25664181
http://dx.doi.org/10.1136/bmjdrc-2014-000049

Ejemplares similares